Anti-cancer effect of Scutellaria baicalensis in combination with cisplatin in human ovarian cancer cell
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6882
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anti-cancer effect of Scutellaria baicalensis in combination with cisplatin in human ovarian cancer cell ; volume:17 ; number:1 ; day:25 ; month:5 ; year:2017 ; pages:1-10 ; date:12.2017
BMC complementary and alternative medicine ; 17, Heft 1 (25.5.2017), 1-10, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Choi, Bo Yoon
- Beteiligte Personen und Organisationen
-
Joo, Jong Cheon
Lee, Yeon Kyu
Jang, Ik-Soon
Park, Soo Jung
Park, Yoon Jung
SpringerLink (Online service)
- DOI
-
10.1186/s12906-017-1776-2
- URN
-
urn:nbn:de:1111-201706094848
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Choi, Bo Yoon
- Joo, Jong Cheon
- Lee, Yeon Kyu
- Jang, Ik-Soon
- Park, Soo Jung
- Park, Yoon Jung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes
Anti-cancer effects of Kaempferia parviflora on ovarian cancer SKOV3 cells
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer
FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway
Best serum biomarker combination for ovarian cancer classification
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes
Anti-cancer effects of Kaempferia parviflora on ovarian cancer SKOV3 cells
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer
FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway
Best serum biomarker combination for ovarian cancer classification
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes
Anti-cancer effects of Kaempferia parviflora on ovarian cancer SKOV3 cells
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer
FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway
Best serum biomarker combination for ovarian cancer classification
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines